Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01946503 · ClinicalTrials.gov registry record
Infant & Toddler Short Gut Feeding Outcomes Study
A clinical trial, sponsored by Children's Hospital Los Angeles.
- Completed
- Registry status
- 58
- Enrollment target
NCT01946503: Completed study, sponsored by Children's Hospital Los Angeles.
NCT01946503 is a clinical trial that has completed, run by Children's Hospital Los Angeles. The registered enrollment target is 58 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01946503 has completed, sponsored by Children's Hospital Los Angeles.
- COMPLETED
- Registry status
- 58 participants
- Enrollment target
Study Summary
The purpose of this study is to better understand why children with short gut develop feeding problems.
Primary Outcome
Data will be reviewed starting at the patient's birth. We will only be looking at patients who have been seen in the clinic since July 1, 2008; some of these will have medical records going back as early as 2006. We will continue to collect future data for up to 1 year from the beginning of data collection.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 58 participants |
| Start Date | 2013-04 |
| Est. Completion | 2023-05-31 |
What the finished NCT01946503 record still lists
NCT01946503 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 58 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01946503 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01946503 about?
NCT01946503 is a clinical study titled "Infant & Toddler Short Gut Feeding Outcomes Study". The purpose of this study is to better understand why children with short gut develop feeding problems.
What is the current status of trial NCT01946503?
This trial is currently completed. The enrollment target is 58 participants. The study started on 2013-04. Estimated completion is 2023-05-31.
Who is sponsoring clinical trial NCT01946503?
This trial is sponsored by Children's Hospital Los Angeles, which has 119 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03587844 · 58 participants · Phase 2
Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients
- NCT03630991 · 58 participants · Phase 1
Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy
- NCT03949855 · 58 participants · Phase 2
Belimumab With Rituximab for Primary Membranous Nephropathy
- NCT04069273 · 58 participants · Phase 2
Novel SEQUEnced Immunotherapy With Anti-angiogenesis and Chemotherapy in Advanced gastroesophageaL Adenocarcinoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia